Table 4. Summary of KRAS mutation analysis of 49 clinical samples.
Mutated Cases | |||
---|---|---|---|
cDNA Positions | Protein Positions | PCR | WTB-PCR |
c.34G>C | p.G12R | 1 | 1 |
c.34G>T | p.G12C | 1 | 1 |
c.34G>A | p.G12S | ND | 1 |
c.35G>C | p.G12A | 2 | 5 |
c.35G>T | p.G12V | 1 | 3 |
c.35G>A | p.G12D | 6 | 9 |
c.37G>C | p.G13R | ND | 1 |
c.37G>T | p.G13C | 1 | 2 |
c.37G>A | p.G13S | ND | ND |
c.38G>C | p.G13A | ND | ND |
c.38G>T | p.G13V | ND | ND |
c.38G>A | p.G13D | 7 | 7 |
TOTAL | 19 | 30 | |
Percent | 38.8% | 61.2% |